Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study

Benzer Materyaller

• A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention
  Yazar:: Kassaian, Seyed-Ebrahim, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial
  Yazar:: Hossein Farshidi, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-03-01)
• Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort
  Yazar:: Franey, Ericha G, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Mean Platelet Volume as a Predictor of One-Year Major Adverse Cardiac Events following Elective Percutaneous Coronary Interventions
  Yazar:: Nozari, Younes, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality
  Yazar:: Christos Eftychiou, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-01-01)